Pharmacielo Stock Retained Earnings
PCLO Stock | CAD 0.06 0.01 10.00% |
Fundamental analysis of Pharmacielo allows traders to better anticipate movements in Pharmacielo's stock price by examining its financial health and performance throughout various phases of its business cycle.
Last Reported | Projected for Next Year | ||
Retained Earnings | -207.9 M | -197.5 M |
Pharmacielo | Retained Earnings |
Pharmacielo Company Retained Earnings Analysis
Pharmacielo's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Pharmacielo Retained Earnings | (207.85 M) |
Most of Pharmacielo's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmacielo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pharmacielo Retained Earnings Driver Correlations
Understanding the fundamental principles of building solid financial models for Pharmacielo is extremely important. It helps to project a fair market value of Pharmacielo Stock properly, considering its historical fundamentals such as Retained Earnings. Since Pharmacielo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pharmacielo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pharmacielo's interrelated accounts and indicators.
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition |
Based on the latest financial disclosure, Pharmacielo has a Retained Earnings of (207.85 Million). This is 122.32% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The retained earnings for all Canada stocks is 102.23% higher than that of the company.
Pharmacielo Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmacielo's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pharmacielo could also be used in its relative valuation, which is a method of valuing Pharmacielo by comparing valuation metrics of similar companies.Pharmacielo is currently under evaluation in retained earnings category among its peers.
Pharmacielo Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pharmacielo from analyzing Pharmacielo's financial statements. These drivers represent accounts that assess Pharmacielo's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pharmacielo's important valuation drivers and their relationship over time.
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Market Cap | 234.1M | 142.7M | 26.4M | 28.8M | 33.1M | 31.5M | |
Enterprise Value | 229.7M | 145.8M | 38.8M | 47.1M | 42.4M | 40.2M |
Pharmacielo Fundamentals
Return On Equity | -30.13 | ||||
Return On Asset | -0.14 | ||||
Profit Margin | (2.63) % | ||||
Operating Margin | (0.35) % | ||||
Current Valuation | 30.39 M | ||||
Shares Outstanding | 182 M | ||||
Shares Owned By Insiders | 7.80 % | ||||
Shares Owned By Institutions | 0.18 % | ||||
Number Of Shares Shorted | 40.42 K | ||||
Price To Book | 9.48 X | ||||
Price To Sales | 2.88 X | ||||
Revenue | 3.48 M | ||||
Gross Profit | 730.88 K | ||||
EBITDA | (4.53 M) | ||||
Net Income | (9.14 M) | ||||
Cash And Equivalents | 33.46 M | ||||
Cash Per Share | 0.34 X | ||||
Total Debt | 15.85 M | ||||
Debt To Equity | 2.70 % | ||||
Current Ratio | 7.36 X | ||||
Book Value Per Share | (0.04) X | ||||
Cash Flow From Operations | (1.97 M) | ||||
Short Ratio | 0.79 X | ||||
Earnings Per Share | (0.05) X | ||||
Target Price | 2.5 | ||||
Beta | 1.8 | ||||
Market Capitalization | 10.01 M | ||||
Total Asset | 18.39 M | ||||
Retained Earnings | (207.85 M) | ||||
Working Capital | (18.8 M) | ||||
Net Asset | 18.39 M |
About Pharmacielo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmacielo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmacielo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmacielo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharmacielo Stock Analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.